MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-24-2026
Medtronic PLC Operating Income 2011-2026 | MDT
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Medtronic PLC
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.96 B | 5.14 B | 5.48 B | 5.75 B | 4.48 B | 4.79 B | 6.27 B | 6.64 B | 5.38 B | 5.36 B | 3.77 B | 3.81 B | 4.4 B | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.64 B | 3.77 B | 5.17 B |
Quarterly Operating Income Medtronic PLC
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.46 B | 1.69 B | 1.44 B | - | 1.65 B | 1.6 B | 1.28 B | - | 1.48 B | 1.34 B | 1.27 B | - | 1.39 B | 1.4 B | 1.12 B | - | 1.28 B | 1.56 B | 2.42 B | - | 1.64 B | 930 M | 930 M | 673 M | 1.54 B | 1.35 B | 1.35 B | 1.48 B | 1.44 B | 1.54 B | 1.54 B | 1.24 B | 1.15 B | 1.89 B | 1.9 B | 1.39 B | 1.36 B | 1.38 B | 1.38 B | 1.17 B | 1.28 B | 1.3 B | 1.3 B | 1.13 B | - | 1.03 B | 1.09 B | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.42 B | 673 M | 1.39 B |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aziyo Biologics
AZYO
|
-30.5 M | - | 1.37 % | $ 20.5 M |  USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 39.27 | -1.36 % | $ 5.85 K | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-5.13 M | $ 7.82 | 4.13 % | $ 561 M |  Israel |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
-24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 9.4 | -2.49 % | $ 1.27 B | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.99 | -2.68 % | $ 149 M |  France |
 |
CONMED Corporation
CNMD
|
103 M | $ 43.41 | -5.2 % | $ 1.35 B | USA |
 |
Electromed
ELMD
|
9.66 M | $ 23.98 | -0.5 % | $ 203 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
-7.85 M | $ 29.83 | -2.68 % | $ 1.37 B | USA |
 |
Apyx Medical Corporation
APYX
|
-17.3 M | $ 3.17 | -3.35 % | $ 110 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.5 | -0.32 % | $ 121 M | USA |
 |
Accuray Incorporated
ARAY
|
7.84 M | $ 0.53 | -4.57 % | $ 54.5 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Medigus Ltd.
MDGS
|
-9.9 M | - | 10.28 % | $ 55.5 M | Israel |
 |
Cytosorbents Corporation
CTSO
|
-16.8 M | $ 0.8 | 6.81 % | $ 43.5 M | USA |
 |
Align Technology
ALGN
|
608 M | $ 182.64 | -3.38 % | $ 13.7 B | USA |
 |
Inari Medical
NARI
|
-28.1 M | - | - | $ 4.23 B | USA |
 |
Butterfly Network
BFLY
|
-74.4 M | $ 3.68 | -4.42 % | $ 779 M | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
8.05 B | $ 113.61 | -0.45 % | $ 198 B | USA |
 |
Nevro Corp.
NVRO
|
-126 M | - | - | $ 217 M | USA |
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
3.61 B | $ 73.85 | -3.11 % | $ 109 B | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 1.98 | -6.6 % | $ 1.2 M | USA |
 |
Alphatec Holdings
ATEC
|
-82.1 M | $ 13.02 | -3.34 % | $ 1.95 B | USA |
 |
InMode Ltd.
INMD
|
85.4 M | $ 13.6 | -0.29 % | $ 879 M | Israel |
 |
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 85.28 | -2.18 % | $ 49.9 B | USA |
 |
IRIDEX Corporation
IRIX
|
-10 M | $ 1.43 | 1.42 % | $ 23.1 M | USA |
 |
IRadimed Corporation
IRMD
|
22 M | $ 104.29 | 0.53 % | $ 1.32 B | USA |